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ABSTRACT
Developing a modular synthetic route to a combinatorial library of functional nanoparticles
for applications like drug delivery is one of the main interests of our group. To this end, we
have envisioned a novel nanoparticle architecture called a brush-arm star polymer (BASP),
which has polymer brushes on the periphery shielding the core. Such nanoparticles were
synthesized by, first, "graft-through" ring-opening metathesis polymerization (ROMP) of a
norbornene-macromonomer to create the brush-arms, and second, cross-linking the arms
with a bis-norbornene cross-linker to afford star polymers via the "arm-first" star polymer
method. Functionality can be installed into the macromonomer (MM) or crosslinker pre-
and post-polymerization. We took advantage of the highly efficient third-generation
Grubbs catalyst to polymerize a polyethylene glycol (PEG) macromonomer (MM) and a bis-
norbornene nitrobenzyloxycarbonyl (NBOC) photocleavable cross-linker to cross-link the
brush-arms, which led to low-dispersity (D 51.23) core-degradable BASPs. Controlled
degradation of these star polymers was achieved by UV irradiation (365 nm).
Next, a novel branched norbornene-polystyrene (PS)-polylactide (PLA)-MM was used to
create pseudo-alternating copolymers and miktoarm-BASPs. Transmission electron
miscroscopy (TEM) of these star polymers revealed nanoparticles with segregated domains.
Also, new cross-linkers were explored containing two different bis-norbornene reversible
addition-fragmentation chain-transfer (RAFT) agents. A more flexible RAFT initiator cross-
linker led to high-dispersity (D >1.52) BASPs, while the more rigid RAFT initiator cross-
linker led to low-dispersity (D 51.05) BASPs.
Finally, doxorubicin-loaded, photocleavable drug vector BASPs were synthesized from
azide-functionalized BASPs. Copper-catalyzed azide-alkyne cycloaddition (CuAAC) was
utilized to covalently link doxorubicin to the azide BASPs, post-polymerization. These
BASPs degraded and simultaneously released their drug payload upon UV irradiation. MTT
assays were conducted with these nanoparticles on MCF-7 human breast cancer cells and
were shown to be non-toxic before UV irradiation and toxic afterward.
Thesis Supervisor: Jeremiah A. Johnson
Title: Assistant Professor of Chemistry
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Chapter I: Water-Soluble Photocleavable BASPs
Introduction
The challenge of constructing a combinatorial library of varied sized, functional
polymeric nanoparticles has thus far limited their production.1, 2 Yet, the production of a
library of varied sized polymeric nanoparticles in a simple and quick fashion could be
advantageous to rapidly screening them for multiple parameters at a time (e.g., screening
drug vectors against multiple conditions). Because polymerization of functional building
blocks is the crucial step in building such nanoparticles, one needs a highly efficient,
functional group-tolerant polymerization method. Ring-opening metathesis
polymerization (ROMP) catalyzed by the third generation Grubbs 3 catalyst is one of the
most efficient, functional group-tolerant polymerization methods known to date.4 -14 This
polymerization method has been used to create bottle-brushl4-17, bivalent bottle-brush18-21,
and dendronized polymers9,2 2 -2 4 via "graft-through" polymerization of bulky
macromonomers. Graft-through polymerization is the synthesis of brush polymers via a
macromonomer that has a polymerizable group at one end. We envisioned using a
combination of graft-through polymerization and "arm-first" star polymer synthesis to
make novel polymeric nanoparticles. Star polymers can be synthesized via one of three
ways: "core-first"25 -35, "coupling-onto" 2 6,28, or "arm-first"28,36-47 polymerization. In core-first
star synthesis, the core of the star is formed with polymerization initiation sites on the
periphery, followed by graft-from polymerization from the core to produce the arms of the
star polymer. Coupling-onto star formation involves the reaction of polymers with reactive
4
end groups and pre-formed cores with complimentary reactive groups. Arm-first star
synthesis involves the cross-linking of "arm" initiators with a multifunctional cross-linker.
We report here the synthesis of water-soluble brush-arm star polymers (BASPs) via
a graft-through arm-first approach. A polyethylene glycol (PEG) macromonomer was
polymerized via the graft-through method to yield brush-arm initiators. The brush
initiators were then introduced to a photocleavable bis-norbornene cross-linker to form
star polymers via the "arm-first" method. The sizes of these nanoparticles were dependent
on the amount of cross-linker added. These particles were also capable of degrading to
smaller BASPs and in some cases their parent brushes upon UV irradiation (365 nm).
Results and Discussion
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Figure 1.48 Synthesis of PEG BASP via graft-through polymerization of 2, then cross-linking of brush initiators with 3.
The BASP degrades upon UV irradiation.
Synthesis of BASPs: BASPs were synthesized by adding one equiv of Grubbs catalyst 1 to 10
equiv of PEG-MM (2) in tetrahydrofuran (THF). The 10-unit brush (Bi) serves as the brush
initiator for the cross-linking polymerization. After 10 minutes of polymerization, aliquots
of the brush initiator solution were added to vials containing 10, 15, and 20 equiv of cross-
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linker (3). The polymerizations were allowed to proceed for 4 hrs before they were
quenched with ethyl vinly ether and dried in vacuo.
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Figure 2.48 (A) Differential weight fraction GPC traces of BASPs after 4 h cross-linking in THF. Inset- Transmission
electron microscopy image of N= 20. (B) Normalized refractive index response GPC traces of BASPs after 6 h cross-
linking in dicholormethane. (C) Log2 plot of Mw versus N from part B. Linear fitting of Mw produces Equation 1, which
relates Mw to N.
The molecular weight (Mw) of the brush initiator and BASPs were determined by gel
permeation chromatography (GPC) coupled with a multi-angle laser light scattering
(MALLS) detector. Figure 2A shows the differential weight fraction plots of the brush
initiator and BASPs. The brush had an expected Mw of 28.5 kDa and a low dispersity index.
The 10 xL BASP was multimodal, while the 15 xL and 20 xL BASPs produced monomodal
differential weight fraction plots. The most interesting aspect of this synthetic route were
that the final BASP size converged to a uniform distribution as a function of the amount of
cross-linker added (N) and the BASPs' Mw doubled for every additional 5 equiv of cross-
linker 3. Also, these nanoparticles were readily water-soluble due to the PEG on their
periphery.
Next, the synthesis of these BASPs was carried out over a wider range of equivalents
of 3 and using a different solvent (DCM) to see if this geometric increase in MW could be
reproduced over these varied reaction conditions. BASPs were synthesized where the
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cross-linker equivalents were varied from N = 10 to 40 with increments of 5. GPC analysis
of these samples, Figure 2B, showed monomodal refractive index response and extremely
high conversion of brush initiator to BASPs. The BASPs, indeed, showed a doubling of Mw
from N = 10 to 40 with increments of 5. Figure 2C shows a linear correlation of the log2
plot of Mw versus N.
A Stage I: chain-growth synthesis of low PDI bottle-brush initiator:
'OY" ownpi-i S
0oup9 norbomene brun poymer ingialo (0,)
Stage I : only certain star-star coupling reactions occur:
Figure 3.48 Proposed method for geometric Mw increase in BASPs synthesis.
Mechanistic Hypothesis: An explanation for the doubling of the Mw of the BASPs is outlined
in the mechanism in Figure 3. There are three stages in the proposed mechanism. During
stage I, a living brush is generated with DP = m followed by the addition of N equivalents of
7
cross-linker that creates the "primary brush initiator" (B1). A key observation is that if all
BASPs reacted equally then that would lead to a classical step-growth polymerization and
the dispersity would approach 2.0 at high conversion. 49 However, lower dispersities can be
reached if BASP coupling is inhibited with increased size.50 ,s1 Stage II shows the most
kinetically favorable reaction, B1+B1, leading to B2 . If k1+2 << k1+1, then there should be a
greater amount of B2; Bi would be consumed which in turn will suppress B3. The reaction
is not complete after the production of B2 ; there are still living initiation sites that can lead
to further coupling reactions. Stage III can be understood by studying the rate laws for B4,
Bs, B6, and B7. The dimerization of B2 is the next most favorable reaction. The low
concentration of Bi and B3 leads to the suppression of Bs, B6, and B7. Dimerization of the
most viable products continues until a final value of x is reached. This proposed
mechanism leads to BASPs with low dispersities and a geometric Mw increase. It should be
noted that the suppressed Bx's are formed in small amounts so it is ideal to find conditions
that will reduce their production.
Degradation of BASPs: The cross-linker 3 contains a nitrobenzyloxycarbonyl (NBOC) group
that is known to cleave upon UV irradiation.5 2-55 Therefore, these BASPs should degrade
from larger sized particles to smaller ones upon UV irradiation. The degradation of these
particles was monitored in aqueous solutions by dynamic light scattering (DLS).
A 1 mg/mL solution of BASPs were made and their hydrodynamic radii (Rh) was
obtained by DLS. The samples were then subjected to UV (365 nm) irradiation for 10 min
and their Rh were measured again. Figure 4B shows the diameters measured before and
after UV irradiation. The stars showed a significant size decrease after UV irradiation.
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However, the larger stars (N = 30 - 40) did not degrade to the same size as the smaller
stars. This can be explained by considering that larger BASPs have a much greater number
of NBOC groups in the core, all of which must be cleaved to achieve complete degradation.
Various factors (limited light absorption, side reactions, etc...) could lead to less than 100%
complete photoreaction, which would in turn limit particle degradation. These effects
would be magnified for the larger particles with more NBOC groups.
A B
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20- 20-OTIIJ 040w 15
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Figure 4.48 (A) DLS histograms of BASPs (N= 15, 30, 40) before and after UV irradiation. (B) Hydrodynamic diameter of
BASPs (N= 10 - 40) before and after UV irradiation.
Conclusion
Water-soluble, photocleavable BASPs were successfully prepared using a novel
"brush-first" synthetic route. This method made it easy to produce a library of
nanoparticles, the sizes of which were controlled by the relative amount of cross-linker
added during star formation. These stars showed a geometric M" increase with each 5
equiv increase of cross-linker added. They also were capable of degrading upon UV
irradiation; the extent of degradation decreased as the size of the star increased because of
9
the increased amount of PEG surrounding the core limiting the penetration of UV
irradiation.
Experimental Methods
All reagents and solvents were purchased from Aldrich or VWR and used as supplied unless
otherwise noted. All synthetic procedures can be found in the literature publication that
describes this work.48 Degassed dichloromethane (DCM) and tetrahydrofuran (THF) were
passed through solvent purification columns prior to use.5 6
Gel permeation chromatography (GPC) was performed using two Shodex KD-806M GPC
columns connected in series with a DAWN EOS 18 angle laser light scattering (MALLS)
detector (Wyatt Technology) and a T-rEX refractive index detector (Wyatt Technology).
Experiments were performed at room 60 *C using 0.2 M LiBr in N,N-dimethylformamide
(DMF) eluant at a flow rate of 1 mL / min. Molecular weights were calculated from dn/dc
values that were obtained assuming 100% mass elution from the columns. Dynamic light
scattering (DLS) measurements were made at room temperature using a Brookhaven
ZetaPALS DLS instrument. Samples were dissolved in nanopure water at a concentration of
-1 mg / mL. A fresh, clean, polystyrene cuvette was washed with compressed air to
remove dust. The sample solution was passed through a 0.4 ptm Teflon syringe filter
directly into the cuvette; the cuvette was capped and placed in the DLS instrument for
particle sizing. At least 3 measurements were made per sample and average hydrodynamic
diameters were calculated by fitting the DLS correlation function using the CONTIN routine
(ISDA software package from Brookhaven instruments). Nuclear magnetic resonance
(NMR) experiments were performed on either a VARIAN Mercury 300 MHz spectrometer,
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Bruker AVANCE-400 NMR spectrometer, or a VARIAN Inova-500 MHz spectrometer.
MestReNove NMR 8.1.2-11880 software was used to analyze the NMR spectra. Analytical
high-performance liquid chromatography mass spectrometry (HPLC-MS or LC-MS) data
were obtained using an Agilent 1260 series HPLC system equipped with a variable
wavelength ultraviolet-visible (UV-Vis) detector and an Agilent 6130 single quadrupole
mass spectrometer. Separation was achieved using an Agilent Zorbax SB-C18 semi-
preparative column (HPLC) or Agilent Zorbox SB-C18 rapid resolution HT column (LC/MS)
with mobile phase gradients of 0.1% acetic acid in water and acetonitrile. Experiments
were performed at room temperature with a flow rate of 5.0 mL / min (HPLC) or 1.0 mL /
min (LC/MS). High-resolution mass spectrometry data were obtained on a Bruker
Daltonics APEXIV 4.7 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometer
(FT-ICR-MS). P otolysis experiments were performed using a Multiple Ray Lamp (UVP)
fitted with an 8 W, longwave, filtered blacklight bulb (365 nm). Sample vials were placed
as close as possible to the light source and irradiated for the desired time before analysis
by DLS. TEM images were obtained at the MIT Center for Materials Science and
Engineering (CMSE) on a JEOL 200CX TEM instrument with a 1k x 1k CCD camera. Sample
preparation was as followed: 5.0 uL of a 0.05 mg / mL solution of BASP was deposited on
top of a carbon film-coated 200-mesh copper grid placed on a piece of parafilm carbon-
coated side up. The sample was allowed to dry and then placed carbon-coated side up on
top of a LC/MS vial covered with foil. The LC/MS vial was placed inside a 20mL
scintillation vial and to the scintillation vial was added -0.30 mL of a 4% Os04(aq); the
scintillation vial was capped and allowed to stand overnight. The grid was removed and
then analyzed for TEM imaging.
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Chapter II: Polystyrene-Polylactic acid BASPs
Introduction
Block copolymers are an extremely useful class of materials. 5 7-71 The properties of block
copolymers could be precisely encoded through combining different polymer blocks in
specific sequences. 72-78 This stands in contrast to random copolymerization of two or more
monomers or MMs, in which achieving an exact 1:1 stoichiometry of each block polymer is
impossible due to the inherent statistical nature of the process. However, overcoming this
problem could be solved by installing the polymers of choice in a single MM, then
polymerizing that MM to yield block copolymers with an exact 1:1 ratio on each polymer.
Polymerizing a single MM with two polymers attached is the only way to achieve a 1:1 of
the polymers of choice. Having the ability to control the exact ratio of polymers in block
copolymers can lead to a wide array of new properties. With this in mind, we report here
the synthesis and polymerization of a novel branched-norbornene-polystyrene(PS)-
polylactic acid (PLA) MM. The polymerization of this MM produced monodisperse bivalent
bottle-brush copolymers. This MM was also copolymerized with a PEG-MM. Monodisperse
diblock copolymers were only afforded when the PS-PLA MM was the first block;
copolymers and reverse diblock copolymers yielded polymers with low conversions. This
new PS-PLA MM was utilized to make miktoarm BASPs; miktoarm BASPs were also made
with PS-PLA-b-PEG brush initiators.
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Results and Discussion
Synthesis of PS-PLA MM: A branched structure was needed in order to append multiple
polymers to one MM. Therefore, we used a previously published norbornene-alkyne-NHS
ester 19 as the starting point for our PS-PLA MM synthesis. Figure 5 outlines the synthetic
route to achieve PS-PLA MM 7. NHS-ester 4 was coupled to 3-amino propanol to afford the
alcohol 5. Next, a 4k polystyrene (PS) azide was coupled to 5 using copper-catalyzed azide
alkyne cycloaddition (CuAAC) to afford 6. Polylactide (PLA) was grown from 6 by tin(II)
mediated ring opening polymerization to afford the final PS-PLA MM 7.
N 0 0
0 OOJ
H2N"-'OH
DCM, 1 h, RT
4
k 0 0 HO N k_,-,yN -0OH
0 0
5
CuBr, PDMETA,66 DMF, 24 hrs, 70 *C
0
YTOOY)K
0
0.1 Tin(II)ethylhexanoate
Toluene, 1 h, 106 0C
6
Figure 5. Synthetic scheme of branched PS-PLA MM (7).
Polymerization of PS-PLA MM: MM 7 (100 equiv) was treated with one equiv of 1, to afford
brushes with a molecular weight of 808 kDa, relatively low dispersity (D=1.10), and high
conversion (>90%). The 100 unit bivalent bottle-brush made from 7 has an equal ratio of
PS to PLA arranged in a perfectly alternating fashion because each repeat unit has both PS
13
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and PLA extended from the backbone. It would be impossible to make similar brushes with
independent PS and PLA MM. After successfully making a monodisperse brush with 7, it
was copolymerized with 2 to make a bivalent bottle-brush block copolymer with three
polymer domains.
Synthesis of a random copolymer and two diblock copolymers were attempted with
7 and 2, simultaneously. The first diblock copolymer (DB1) was synthesized by allowing 7
to polymerize first; followed by the addition of 2. The other diblock copolymer (DB2) was
synthesized in the reverse order; polymerization of 2 followed by the addition of 7. The
random copolymer was synthesized by adding both 7 and 2 to a vial before addition of 1.
The GPC traces in Figure 6B shows DB1 polymerized well, -80% conversion, while both
DB2 and the random copolymer failed to reach greater than 20% conversion. Once 2
begins to polymerize, it shuts down the addition of 7 into the brush, which prevented the
formation of the random copolymer and DB2. Due to this observation, all further block
copolymers were made following the DB1 procedure.
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Figure 6. (A) Refractive index GPC trace of 7 and 100 unit brush made from 7. (B) Refractive index GPC trace of DB1, DB2,
and Random copolymer; all made from 7 and 2.
Table 1. GPC characterization of homopolymerization of 7 and block and random copolymers made from 7 and 2.
DPnb Mw (kDa) D
DB1 100:100 98:98 1,170 1.03
Random
copolymer
.a Ratio of macromonomer(s)
100:100 - 14.7
to catalyst. b Degree of polymerization determined by Mw (GPC)/Mw (MM)
Synthesis of Mitkoarm-BASPs: BASPs were synthesized using the same procedure from
Chapter I.48 The initial stars using 10-unit brush initiators showed poor conversion of
brush initiator to star polymer as judged by the appearance of multimodal peaks in GPC
15
- PS-PLA MM (7)
- 100-unit BrushI0.80.6
0.4
0.2
0.0
15 20
Sample MM:1a
B
traces. Inefficient star formation might be due to the bulkiness of 7; having two polymer
domains instead of one surrounding the star-star coupling initiation site might reduce the
efficiency of the star-star coupling reaction. Reducing the length of the brush initiator will
reduce the steric hindrance around the star-star coupling sites. The latter should lead to
greater efficiency of star-star coupling. Thus, for these studies a 5-unit brush was
polymerized and used as the brush initiator. Figure 7A shows monomodal GPC traces of
these BASPs. This procedure led to several low-dispersity (D 1.11) PS-branch-PLA BASPs
with high MM conversion (>95%).
Next, BASPs were made using DB1 triblock polymers as brush initiators. 5-unit
brush initiators proved to be successful with BASPs made from 7, therefore the same size
brush initiators were used with DB1. These BASPs are particularly interesting because they
have 3 polymer domains extending from the core.
16
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Figure 7. (A) Refractive index GPC traces of brush initiator and BASPs (N = 10 - 40) made from 7. (B) Transmission
electron microscopy image of BASP N = 30. (C) Refractive index GPC traces of brush initiator and BASPs (N = 10, 15, 20)
made from DB1. (D) Transmission electron microscopy image of BASP N = 20. TEM sample preparation: A solution (0.05
mg/mL) of BASP in THF was drop-casted onto a copper TEM grid. The grid was stained with 0.5% RuO4(aq) for 30 min.
Table 2. GPC characterization of brush initiators and BASPs made from 7 and DB1.
Sample
5-1UxL
M. (kDa) D
/ 5 1.Ub
5-30xL 2,832 1.11
Brush (DBI) 31.4 1.05
5-15xL 458 1.15
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TEM images of BASPs using 7 and DB1 are shown in Figure 7B and 7D, respectively.
Both BASPs were dissolved in THF to make a 0.05 mg/mL solution. 4 ptL of each solution
were drop-casted on separate copper TEM grids. The THF was allowed to evaporate and
then each grid was stained with RuO4 for -30 min. Both Figure 7B and 7D show spherical
type particles with areas of lighter and darker shades. These photos suggest that there is
phase segregation in the BASPs, but determining which segment is which polymer will
require further investigation.
Conclusion
This chapter detailed the synthesis and use of a novel branched MM that possess
two polymer domains, PS and PLA. This MM was shown to produce monodisperse
homopolymers and diblock copolymers with 2. Both polymers were used as brush
initiators to produce miktoarm BASPs with 3. Transmission electron microscopy (TEM)
images of these BASPs show the phase segregation of the different polymer domains.
Experimental Methods
All reagents and solvents were purchased from Aldrich or VWR and used as supplied unless
otherwise noted. Norbornene-Alkyne-N-Hydroxysuccinimidy (NHS)-Ester 419 was
prepared according to literature procedures. Degassed tetrahydrofuran (THF) was passed
through solvent purification columns prior to use.56
Instrumentation was the same from Chapter I. TEM images were obtained at the MIT
Center for Materials Science and Engineering (CMSE) on a JEOL 200CX TEM instrument
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with a 1k x 1k CCD camera. Sample preparation was as followed: 5.0 uL of a 0.05 mg / mL
solution of BASP was deposited on top of a carbon film-coated 200-mesh copper grid
placed on a piece of parafilm carbon-coated side up. The sample was allowed to dry and
then placed carbon-coated side up on top of a LC/MS vial covered with foil. The LC/MS vial
was placed inside a 20mL scintillation vial and to the scintillation vial was added -0.30 mL
of a 0.5% RuO4(aq); the scintillation vial was capped and allowed to stand for 30 min. The
grid was removed and then analyzed for TEM imaging.
Norbornene-alkyne-alcohol (5)- Dichloromethane (0.1 M) was used to dissolve 4 (200 mg,
0.402 mmol). To that solution, 3-aminopropyl alcohol (45.3 mg, 0.603 mmol) was added
and allowed to stir at room temperature until the disappearance of 4 by thin layer
chromotagraphy (TLC, Rf - 0.3 in dichloromethane)- 30 min. The reaction mixture was
then added directly to a silica gel column and flashed at dicholormethane to afford 5 as a
clear viscous liquid (79 % yield). 'H NMR (400 MHz, Chloroform-d) 6 7.00 (s, 1H), 6.17 (s,
2H), 3.99 (dd,J = 19.0, 2.5 Hz, 2H), 3.47 (tJ = 5.7 Hz, 2H), 3.37 - 3.17 (m, 6H), 3.13 (s, 2H),
2.65 (tJ = 6.6 Hz, 1H), 2.59 (s, 4H), 2.48 - 2.36 (m, 2H), 2.27 (tJ = 2.4 Hz, OH), 2.14 (tJ =
2.4 Hz, 1H), 1.61 - 1.34 (m, 7H), 1.28 - 1.02 (m, 5H). 13C NMR (101 MHz, CDCl 3) 6 178.02,
173.53, 172.35, 172.03, 171.68, 137.63, 78.84, 77.16, 71.69, 59.14, 47.62, 44.96, 42.57,
38.38, 38.26, 36.12, 34.64, 31.80, 30.98, 28.45, 27.94, 27.37, 27.07, 26.36, 26.03, 25.31.
Norbornene-polystyrene-alcohol (6)- To a mixture of 5 (137 mg, 0.30 mmol)
copper(I)bromide (41 mg, 0.286 mmol), N,N,N',N",N"-pentamethyldiethylenetriamine
(PMDETA, 298 uL, 1.4 mmol), and polystyrene-azide (1.1 g, 0.286 mmol) anhydrous DMF
was added (3 mL). The reaction was allowed to heat and stir at 70 'C for 24 hrs. A spatula
tip of azide-resin and alkyne-resin was added to the reaction and allowed to stir overnight.
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At this time, the reaction mixture was cooled to RT and then diluted with THF and run
through a short aluminum oxide column, using tetrahydrofuran (THF) as the eluent. 300
mL of THF was collected, roto-vap down to 2 mL and then precipitated in cold methanol.
The suspension was centrifuged, methanol decanted, solid redissolved in THF and then
precipitated in 20% H20 in methanol. The procedure was repeated 4 times and then placed
under vacuum to dry; this resulted in a white powder 6 (90%).
Norbornene-polystyrene-polylactic acid MM (7) - 3,6-dimethyl-1,4-dioxane-2,5-dione (252
mg, 1.75 mmol), (6) (220 mg, 0.05 mmol) and tin(II)ethylhexanoate (2.0 mg, 0.005 mmol)
was added to a vial and brought into the glovebox. Toluene (2 M) was added to the vial;
then the reaction was heated and stirred at 106 *C for 1 h. The solution was precipitated in
cold methanol, suspension centrifuged, methanol decanted, solid redissolved in a minimal
amount of THF and then precipitated in 20% H20 in methanol. The procedure was
repeated 4 times and then placed under vacuum to dry; this resulted in a white powder 7
(90%).
Polymerization of 7 - MM 7 (11.5 mg, 0.00 1 mmol) was added to a 0.5 dram vial with a stir
bar. THF (0.06 M, 18.7 RL) was added to the vial with 7 and stirred until dissolved. A
0.002 g/mL solution of 1 in THF was made in a separate vial. The solution of 1 (0.01 mg,
5.2 gL) was added to the stirring solution of 7. The polymerization was allowed to stir
from -90 min. A drop of ethyl vinyl ether was added to quench the polymerization. GPC
characterization data is provided in Figure 6A.
Copolymerization of 7 and 2 - (DB1) MM 7 (10 mg, 0.001 mmol) was added to a 0.5 dram
vial with a stir bar. THF (0.06 M, 16.3 RL) was added to the vial with 7 and stirred until
20
dissolved. A 0.002 g/mL solution of 1 in THF was made in a separate vial. The solution of 1
(.009 mg, 4.5 pL) was added to the vial containing 7. This was allowed to stir for -90 min.
MM 2 (4.1 mg, 0.001 mmol) was dissolved in THF (12.5 gL) and then added to the vial
containing the polymerization of 7 and allowed to polymerize for -90 min. One drop of
ethyl vinyl ether was added to quench the polymerization. GPC characterization data is
provided in Figure 6B.
(DB2) This diblock copolymer was synthesized in the reverse order of DB1. GPC
characterization data is provided in Figure 6B.
(Random copolymer) MM 7 (24.7 mg, 0.003 mmol) and 2 (10 mg, 0.003 mmol) were added
to a 0.5 dram vial with a stir bar. THF (0.06 M, 40 gL) was added to the vial containing the
MMs and stirred until dissolved. A 0.002 g,/mL solution of 1 in THF was made in a separate
vial. The solution of 1 (.02 mg, 11.2 gL) was added to the vial containing the MMs. This
was allowed to stir for -90 min. GPC characterization data is provided in Figure 6B.
Miktoarm BASPs - MM 7 (85 mg, .011 gmol) was added to a 0.5 dram vial with stir bar. THF
(0.04 M, 188 RL) was added to the vial with 7 and stirred until dissolved. A 0.02 g/mL
solution of 1 in THF was made in a separate vial. Cross-linker 3 (2.9 mg, 5.9 mg, 8.8 mg,
and 11.8 mg) was added to four separate vials. The solution of 1 (1.5 mg, 77 gL) was added
to the stirring solution of 7. The polymerization was allowed to stir from -15 min. An
aliquot of the polymerization of 7 (20 mg, 62.5 gL) was added to each vial containing cross-
linker. After 6 h, one drop of ethyl vinyl ether was added to quench each polymerization.
GPC and TEM characterization is provided in Figure 7A and Figure 7B, respectively.
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Miktoarm (DB2) BASPs - MM 7 (60 mg, 0.008 mmol) was added to a 0.5 dram vial with a stir
bar. THF (0.04 M, 78.5 gL) was added to the vial with 7 and stirred until dissolved. A 0.02
g/mL solution of 1 in THF was made in a separate vial. The solution of 1 (2.2 mg, 109 gL)
was added to the vial containing 7. This was allowed to stir for -15 min. A 0.204 g/mL
solution of 2 (24.3 mg, 0.008 mmol) was dissolved in THF (119 gL) and then added to the
vial containing the polymerization of 7 and allowed to polymerize for -15 min. Cross-
linker 3 (2.1 mg, 3.1 mg, and 4.2 mg) was added to three separate vials. An aliquot of the
polymerization of DB1 (20 mg, 44.5 gL) was added to each vial containing cross-linker.
After 6 h, one drop of ethyl vinyl ether was added to quench each polymerization. GPC and
TEM characterization is provided in Figure 7C and Figure 7D, respectively.
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Chapter III: Investigation of New Cross-Linkers for BASPs Synthesis: Trithiocarbonate
RAFT Initiators
Introduction
We have shown that this BASP synthetic route can be used with various MMs, however,
until this point we have used the same photocleavable crosslinker. This synthetic route
would be even more useful if both variables, MM and cross-linker, could be varied. Cross-
linkers that respond to various stimuli would increase the functionality of the method. Our
group has previously published a paper on the synthesis of photo-responsive polymeric
networks via the photoinitiated polymerization of NiPAAm from a bis-norbornene
trithiocarbonate RAFT initiator.79 An inverse-demand Diels Alder reaction was conducted
post-polymerization with a tris-tetrazine to form gels. The junctions of the gels were then
extended by added more monomer and solvent to the gel and irradiating it with UV light.
The polymerization was controlled by UV irradiation; the polymerization stopped when the
reaction was in the dark and started again once exposed to UV irradiation. The idea of
polymerizing an already formed polymer was extended to our BASPs synthesis.
Polydisperse BASPs were formed using the previously published bis-norbornene
trithiocarbonate RAFT initiator. A rigid bis-norbornene-3-dibenzyl-trithiocarbonate was
prepared in order to reduce potential cyclization reactions and yield monodisperse BASPs.
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Results and Discussion
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Figure 8. Flexible bis-norbornene trithiocarbonate cross-linker.79
Synthesis of RAFT Agent BASPs: The BASPs synthesis procedure used in earlier chapters
was used here.48 MM 2 was used to make the brush initiators in the following BASPs.
Aliquots of the brush initiator were added to vials containing different equivalents of the
bis-norbornene trithicarbonate cross-linker 8. These polymerizations led to multimodal
and polydisperse samples. When MM 8 was dissolved in THF and added in 5 equiv aliquots
until the desired amount of cross-linker was reached, instead of adding the living brush to
8 the results were much more promising.
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Figure 9. (A) Refractive index GPC traces of brush initiator and BASP (N = 20, 25, 30) made from 2 and cross-linker 8;
using slow addition of 8 method. (B) Differential weight fraction On/Off plot of UV polymerization of NiPAAm from the
core of RAFT BASP (N = 20).
Figure 9A shows more uniform stars, but there was still -10% of unreacted brush initiator.
We reasoned that this incomplete conversion could be due to the flexibility of 8. It has
been proposed that flexible bis-norbornenes that are exposed to third-generation Grubbs
catalyst leads to cyclization of the bis-norbornene. 80 Cyclization in the star synthesis can
lead to inefficient stars polymer synthesis; leading to low star-star coupling conversion and
polydisperse samples. A more rigid cross-linker could potentially suppress the amount of
cyclization; which should lead to more uniform stars. UV polymerization of NiPAAm from
the core of these BASPs were tested before exploring a more rigid cross-linker.
The 10-20xL BASP, NiPAAm (300:1, NiPAAm:8), and a stir bar were added to a microwave
vial, which was subsequently brought into a glove box. Anhydrous acetonitrile (ACN) was
added, the vial capped, and solution allowed to stir for ~1 h. The BASP-NiPAAm solution
was stirred before UV polymerization to make sure the NiPAAm reached the core of the
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A B
sterically hindered BASP in order to be in contact with the RAFT initiator. Next, the
microwave vial was placed in a Rayonet photobox and irradiated for 1 h, then placed in the
dark for 30 min. The procedure was repeated 2.5 times, with aliquots taken for GPC
analysis after coming out of the photobox and right before placing back in the photobox.
An On/Off plot of the differential weight fraction of the BASP versus time is shown in
Figure 9B. This plot is promising in that it suggests that the sterically hindered core of
these BASPs is accessible for polymerization. Therefore, a more rigid cross-linker was
explored in order to produce BASPs with low dispersities.
CI
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Figure 10. Synthetic scheme of bis-norbornene-3-benzyl trithiocarbonate cross-linker (11).
A novel bis-norbornene dibenzyltrithiocarbonate (11) was synthesized in three
steps. Exo-norbornene anhydride, diisopropylethylmine (DIPEA), and 3-aminobenzyl
alcohol were heated in a microwave at 170 *C for 30 min. The resulting alcohol (9) was
converted to the benzylic chloride with cyanuric chloride and DMSO, to yield (10). Next,
10 was converted to 11 by dissolving 10 in DMF and adding carbon disulfide. Potassium
carbonate was added at RT. The reaction was allowed to stir at RT for 24 hrs, yielding 11.
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Cross-linker 11 was used to make a 20xL BASP from 2 and 7. The resulting stars were
uniform with >95% conversion. The rigidity of 11 seems to aide in producing narrowly
dispersed BASPs. Before growing polymer from the core of these stars, UV polymerization
of NiPAAm from 11 was investigated.
SS ACNWTN h,Sh
1.0- Solvent Mw Dispersity
ACN 12 kDa 1.09
- THF 17 kDa 1.38
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Figure 11. (A) Comparison of solvents (THF and ACN)Refractive index GPC traces of UV polymerization of NiPAAm from
bis-norbornene-3-dibenzyl trithiocarbonate RAFT initiator (B) Refractive index GPC traces of brush initiators and BASPs
using PEG-MM (2), PS-PLA MM (7), and cross-linker 11.
Table 3. GPC characterization of brush initiators and BASPs made from MMs 2 and 7 and cross-linker 11.
Sample M. (kDa) D
10-20xL 1,219 1.07
5-20xL 1,033 1.09
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UV Polymerization Using New Trithiocarbonate: UV polymerization of NiPAAm was tested
in both ACN and THF. NiPAAm and 11 were both added to two separate vials and brought
into the glovebox. Anhydrous THF was added to one vial while anhydrous ACN was added
to the other and then both were capped. The vials were placed -1cm from a UV light
source and left for 5 hrs. The polymerization in ACN led to a uniform polymer (D = 1.09,
Mw = 12 kDa), while the polymerization in THF led to a more disperse sample (D = 1.38, Mw
= 17 kDa). UV polymerization of NiPAAm from 11 was better controlled in ACN versus THF.
As stated above, the UV polymerization works best in ACN and these conditions
should be used to grow pNiPAAm from the core of PEG-RAFT. Thermal conditions should
be worked out in order to polymerize the core of RAFT stars that contain PS; UV light could
potentially cross link the PS.
Conclusion
This chapter described the synthesis of multiple BASPs using different RAFT agent
cross-linkers. The high solubility of the 8 led to polydisperse stars, so 8 was added
overtime and this led to increasingly monodisperse sample, but they only reach -90 %
conversion. Preliminary experiments growing pNiPAAm from the core of these BASP
deemed successful due to the increase of Mw after UV irradiation. This led to the
exploration of a more rigid RAFT cross-linker, 11. Cross-linker 11 produced monodisperse
stars with 2 and 7. The size of these stars were controlled by two factors; the amount of
cross-linker added and the size of polymer grown from the core.
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Experimental Methods
All reagents and solvents were purchased from Aldrich or VWR and used as supplied unless
otherwise noted. Trithiocarbonate 879 was prepared and the UV polymerization of
trithiocarbonates7 9 was followed according to literature procedure. Tetrahydrofuran
(THF) was passed through solvent purification columns prior to use.5 6
Instrumentation was the same as Chapter I.
Exo-norbornene-3-benzyl-alcohol (9) - cis-5-norbornene-exo-2,3-dicarboxylic anhydride
(625 mg, 0.610 mmol), 3-aminobenzyl alcohol (516 mg, 0.670 mmol),
diisopropylethylamine (730 uL, 0.670 mmol), and toluene (14 mL) were added to a
microwave vial. This reaction mixture was heated and stirred in a Biotage Initiator+
microwave at 170 'C for 30 m. The solution was placed directly on a silica gel column and
flashed with EtOAc:Hexanes (10% to 30% to 50%). The reaction yielded 9 (79%, Rf - 0.4 at
50%) as a pure white solid. 1H NMR (400 MHz, Methylene Chloride-d2) 6 7.45 (s, 1H), 7.38
(d, 1H), 7.24 (tJ = 2.2 Hz, 1H), 7.14 (dJ = 7.8 Hz, 1H), 6.36 (s, 2H), 4.68 (dj = 0.7 Hz, 2H),
3.35 (t,J= 1.7 Hz, 2H), 2.83 (dJ= 1.4 Hz, 2H), 2.22 (s, 1H), 1.60 (d,J= 9.9 Hz, 1H), 1.49 (dJ
= 9.9 Hz, 1H). 13C NMR (101 MHz, CD2Cl2) 6 177.43, 143.13, 138.33, 132.70, 129.48, 127.25,
125.88, 125.18, 64.63, 48.35, 46.23, 43.33.
Exo-norbornene-3-benzyl-chloride (10) - To a solution of 9 (300 mg, 1.11 mmol) in
anhydrous DMSO (1.1 mL) was added cyanuric chloride (113 mg, 0.61 mmol) in 3 portions
over 5 min. The reaction was allowed to stir at RT and was monitored by TLC until
consumption of the alcohol (1 h). The mixture was then diluted with 100 mL of Et02 and
washed with H20 (5 x 20 mL), dried over sodium sulfate, concentrated on rotary
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evaporator, and purified by flash chromatography with EtOAc:Hexanes (10% to 20% to
30%) to yield 10 (84%, Rf - 0.3 at 30%) as a pure white solid. 1H NMR (400 MHz,
Methylene Chloride-d2) 6 7.49 (s, 1H), 7.44 (dJ = 7.8 Hz, 1H), 7.31 (t, 1H), 7.23 (d,J = 7.6
Hz, 1H), 6.39 - 6.33 (m, 2H), 4.64 (d, 2H), 3.36 (dJ = 1.7 Hz, 2H), 2.85 (tJ = 1.4 Hz, 2H),
1.61 (dJ= 10.0 Hz, 1H), 1.49 (d,J= 9.9 Hz, 1H). 13C NMR (101 MHz, CD2Cl2) 6 177.14,
139.17, 138.35, 132.91, 129.80, 129.05, 126.99, 53.84, 48.35, 46.28, 45.93, 43.36.
Bisnorbornene-3-benzyl-trithiocarbonate (11) - Carbon disulfide (154 uL, 1.61 mmol) was
added to a solution of 10 (700 mg, 2.43 mmol) in anyhydrous DMF (2.43 mL). Potassium
carbonate (336 mg, 2.65 mmol) was added to this mixture. The reaction was then allowed
to heat and stir at RT for 24 h. The reaction was diluted with H20, extracted with EtOAc,
dried over magnesium sulfate, filtered, and concentrated on rotary evaporator. The
resulting solution was purified by flash chromatography and yielded 11 (45%) as a yellow
crystalline solid. 1H NMR (400 MHz, Methylene Chloride-d 2) 6 7.48 - 7.37 (m, 4H), 7.27 (tJ
= 1.7 Hz, 2H), 7.19 (dt,J = 7.3, 1.9 Hz, 2H), 6.36 (s, 4H), 4.67 (s, 4H), 3.35 (d,J = 1.8 Hz, 4H),
2.84 (dJ= 1.4 Hz, 4H), 1.60 (d,J= 9.9 Hz, 2H), 1.48 (dJ= 9.9 Hz, 2H). 13 C NMR (101 MHz,
CD2Cl2) 6 177.10, 138.32, 136.85, 132.82, 129.66, 127.64, 126.24, 48.31, 46.23, 43.35,
41.22, 30.05.
RAFT agent BASPs - MM 2 or 7 was added to a 0.5 dram vial with stir bar. THF was added
to the vial with MM and stirred until dissolved. A 0.02 g/mL solution of 1 in THF was made
in a separate vial. A 0.1 M solution of cross-linker 8 or 11 in THF was made in a separate
vial. Enough solution of 1 was added to the stirring solution of 2 or 7 to make a 10 unit
brush initiator or 5 unit brush initiator, respectively. The polymerization was allowed to
stir for -15 min. Aliquots of the solution of 8 or 11 were added at 5 equiv at a time, every
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5 min, to the vial containing the polymerization of 2 or 7 until the desired equiv of cross-
linker was added. After 30 min, one drop of ethyl vinyl ether was added to quench the
polymerization. GPC characterization is provided in Figure 9A and 11B.
UVpolymerization of NiPAAm from core of RAFT star polymer - RAFT star (10-20xL, 1.4 mg,
0.000614 mmol of 8) made with 8, NiPAAm (21 mg, 0.184 mmol), and a stir bar was placed
in a microwave vial and brought into glove box. Anhydrous ACN (92 gL, 2 M to NiPAAm)
was added to the microwave vial, capped, and the solution was stirred at RT for 1 h to
thoroughly mix the NiPAAm and star to ensure the NiPAAm reaches the core of the star.
The microwave vial is placed in a Rayonet photobox and irradiated for 1 h, then placed in
the dark for 30 min. The procedure was repeated 2.5 times, with aliquots taken for GPC
analysis after coming out of the photobox and right before placing back in the photobox.
An ON/OFF plot of differential weight fraction of the aliquots taken versus time is shown in
Figure 9B.
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Chapter IV: Simultaneous Core Degradation and Drug Release from Drug-Loaded BASPs
Introduction
Studies by Duncan, Kopecek and Ringsdorf in the late 1970's started the vision of
polymer drug conjugates. 81 The use of polymeric materials for biomedical applications has
been a steady growing field over the past decade. 82-119 Synthetic polymers can be tailored
with almost any functionality and architecture: the ability to manipulate a polymers
functionality and architecture gives chemists the tools necessary to mimic some of nature's
most efficient biomaterials. Nanoscopic polymeric materials, specifically branched
polymeric architectures, possess features which make them attractive for in vivo drug
delivery applications. 120 Branched structures of sufficient size display extended in vivo
circulation times in comparison to their linear analogoues - an advantageous feature for
passive tumor targeting via the enhanced permeation and retention effect (EPR effect).
Dendrimers are the most extensively studied branched polymers in this regard; their
monodisperse, globular structures resemble those of proteins and render them attractive
for biological applications.121-146 PEGylated dendrimers have proven effective during in
vivo and in vitro treatment of cancer147-169, but synthetic challenges limit the utility of
dendrimers. We propose a novel synthesis of drug-loaded BASPs that may possess similar
drug-delivery attributes when compared to PEGylated dendrimers.
We report water-soluble polyethylene-glycol (PEG) based BASPs; which possess
photodegradable cores and an anticancer drug (doxorubicin) covalently bound throughout
the shell via photodegradable linkers. Doxorubicin was covalently attached to the BASPs
by utilizing copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry.
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Ultraviolet irradiation (365 nm) leads to simultaneous drug release and degradation of the
BASP core to yield particles with Rh < 12 nm. These nanoscopic materials may be useful for
targeted delivery of cancer chemotherapeutics by taking advantage of the EPR effect
Results and Discussion
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Figure 12. Synthetic scheme of drug-loaded, photocleavable BASP. A brush initiator is made from a chloride-MM; then
cross-linked with 3. The chlorides are converted to azides using NaN3. CuAAC click chemistry is used to covalently bind a
drug molecule to the azide-BASP. UV irradiation degrades the core of the star and simultaneously releases it's drug load.
Obtaining drug-loaded BASPs can come from two methods: polymerizing a drug
loaded macromonomer to create the arms of the BASP or polymerizing a macromonomer
with the ability of functionalizing with a drug derivative post-polymerization. We decided
to explore the latter for these studies.
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Figure 13. Norbornene chloride-MM. 18
Synthesis offunctional BASPs: A chloride macromonomer (12) was tested to see if BASPs
could be made in the same manner as 2 and 7. Using the procedure from Chapter I, several
uniform stars were prepared using 3 as a cross-linker. The stars were dried and the
redissolved in anhydrous DMF, a spatula tip of sodium azide was added; this mixture was
allowed to stir at 40 *C for 48 hrs. IR spectra were taken to confirm the presence of azides;
they have a unique IR stretch, 2100 cm-1. The degradation of the BASPs in response to UV
light was tested in response to UV light in aqueous solution. Figure 14C shows that the
BASPs degrade to smaller sizes (-6 nm in diameter) after UV irradiation.
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Figure 14. (A) Refractive index GPC traces of brush initiator and BASPs, N =10, 12, 14. IR spectrum of azide
functionalized BASP, N = 12, confirming presence of azides. (C) Hydrodynamic radii of BASPs, N = 10, 12, 14, before and
after UV irradiation; measured by DLS.
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Table 3. GPC characterization of brush initiator and BASPs, N = 10-14.
Sample M (kDa) D
10-10xL 423 1.27
10-14xL 865 1.27
0 NO2  0 HQ
N O 1N C
C
HC
C
13
Figure 14. Alkyne-NBOC-doxorubicin.18
CuAAC was utilized to attach a DOX-NBOC-alkyne (13) to the azide BASPs.
Consumption of the azides was confirmed by the disappearance of the IR stretch at 2100
cm-1. After successfully coupling alkyne-DOX to BASPs, the release of free DOX from the
BASPs in response to UV light was studied. An aqueous solution of the drug-loaded BASP
was irradiated at 365 nm for specific times and then analyzed by LC-MS. The release of
free DOX was monitored over a period of 20 min. The amount of free DOX released
increased as the irradiation time increased, as shown in Figure 15B.
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Figure 15. (A) IR comparison of azide-functionalized and DOX-loaded BASP (N= 12) shows disappearance of azide
stretch in DOX-loaded BASP at 2100 cmd1. (B) Release of DOX and degradation from aqueous DOX-loaded BASP (N = 12)
solution after UV irradiation monitored by LC/MS.
Next, cell viability experiments using MCF-7 human breast cancer cells were
conducted to determine if release DOX was therapeutically active. Cells were treated with
aqueous solutions of either free DOX or the corresponding BASP polymer and irradiated
with UV light for 10 min or kept in the dark. The cells were then incubated in the dark for
24 hrs, washed twice, and incubated for another 24 hrs in fresh, drug-free growth medium.
Cell viability was determined by MTT assay. Data from the MTT assay is located in Figure
16. Controls were performed to: establish a baseline for the toxicity of DOX in our system,
determine if UV irradiation affects the toxicity of DOX, and to determine if the non-drug-
loaded BASPs are toxic with and without UV irradiation. Figure 16 shows that the UV
irradiation barely had an affect on the toxicity of DOX. Also, the azide BASPs with and
without UV irradiation were basically non-toxic towards the cells. It should be noted that
the drug-loaded BASPs were at least 1oX more toxic after UV irradiation versus non-
irradiated samples; their toxicities were all comparable to free DOX.
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Figure 16. Cell viability of MCF-7 human breast cancer cells treated with free DOX, azide-BASP (N = 12), DOX-loaded
BASP (N = 10, 12, 14) with and without UV irradiation. Inset: Therapeutic factor for all DOX-loaded BASPs after UV
irradiation.
Conclusion
This chapter described the synthesis and application of drug-loaded BASPs.
Multiple functional BASPs were prepared and an alkyne doxorubicin derivative containing
an NBOC group was used to click to the azide BASPs. Degradation and cargo release from
the drug-loaded BASPs was monitored by DLS and LC/MS, respectively. The drug-loaded
stars toxicity was comparable to free DOX when exposed to UV irradiation in human breast
.cancer cells; the stars were at least 1oX less toxic without UV irradiation.
Experimental Methods
All reagents and solvents were purchased from Aldrich or VWR and used as supplied unless
otherwise noted. Norbornene-chloride-PEG-macromonomer 1218, DOX-NBOC-alkyne 1318,
and trishydroxypropyl triazole170 (TBTA-OH) were prepared according to literature
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procedures. Degassed Tetrahydrofuran (THF) was passed through solvent purification
columns prior to use.5 6 Doxorubicin hydrochloride was purchased from Enzo Life Sciences.
Instrumentation was the same as Chapter I. Spectra/Por 7 dialysis membranes (Spectrum
Labs) were used for azide functionalized BASPs purification. Fourier-transform infrared
spectroscopy (FTIR) experiments were performed on a Perkin-Elmer Model 2000 FTIR
spectrometer under a scrubbed-air atmosphere in transmission/absorbance mode. A
solution of polymer (-10 ptL, -1 mg / mL) in dichloromethane (DCM) was drop-deposited
onto a KBr plate using a Pasteur pipette. After DCM evaporation to give a thin polymer film,
the plate was inserted into the spectrometer and 8 scans were taken at 0.25 cm-1 resolution
from 7800 cm-1 to 370 cm'.
Azidefunctionlized BASP - MM 12 (35 mg, .001 gmol) was added to a 0.5 dram vial with stir
bar. THF (0.06 M, 132 gL) was added to the vial with 12 and stirred until dissolved. A 0.02
g/mL solution of 1 in THF was made in a separate vial. Cross-linker 3 (2.1 mg, 2.8 mg, and
3.4 mg) was added to three separate vials. The solution of 1 (0.7 mg, 36.7 gL) was added to
the stirring solution of 12. The polymerization was allowed to stir from -15 min. An
aliquot of the polymerization of 12 (10 mg, 48.7 gL) was added to each vial containing
cross-linker. After 6 hrs, one drop of ethyl vinyl ether was added to quench each
polymerization. The solvent was removed from each reaction and a spatula tip of NaN3 and
anhydrous DMF (0.8 mL) was added and allowed to heat and stir at 40 *C for 24 hrs. The
solutions were diluted with 3 mL of H2 0, transferred to dialysis bags (MWCO 25 kDa), and
stirred against deionized H20 for 2 days; changing the aqueous solution every 12 hrs. After
dialysis, the BASPs solutions were lyophilized to dryness. Lyophilization resulted in azide
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functionalized BASPs as a white powder. GPC, FT-IR, and DLS characterization data are
provided in Figure 14A, 14B, and 14C, respectively.
DOX loaded BASPs - A stock solution of 13 in DMSO was prepared (16.9 mg 13/ mL DMSO).
A stock solution of sodium ascorbate (1 M) and copper(II)sulfate (1 M) in H20 were
prepared. Azide-BASP (7 mg, 0.002 mmol), TBTA-OH (18 mg, 0.041 mmol), 13 (102 gL),
H20 (1.92 mL, 0.001 M), and a stir bar were added to a microwave vial, capped, and
degassed; then back filled with N2(g). Sodium ascorbate solution (102 RL, 0.1 mmol) and
copper(II)sulfate solution (20.4 gL, 0.020 mmol) were added to the microwave vial and
then heated and stirred at 40*C for 24 h. The samples were then purified by prep-HPLC.
The purified drug-loaded BASPs were concentrated on a rotary evaporator to remove
MeCN. The resulting solution was then either lyophilized to dryness or used directly in
MTT assays. FT-IR characterization data is provided in Figure 15A.
Cell culture - MCF-7 human breast cancer cell line (ATCC, HTB-22) was cultured at 37 'C
under a humidified atmosphere of 5% C02/ 95% air. The cells were grown in Eagle's
Minimum Essential Medium (EMEM, ATCC, 30-2003) supplemented with 10% fetal bovine
serum (Gibco, 10437028), 1% penicillin/streptomycin (Gibco, 105140122), and 10 pg/mL
bovine insulin (Sigma, 10516). The cells were continuously maintained in the culture
medium and subcultured every 3-4 days.
Drug treatment and cell viability assay - MCF-7 cells were seeded at 10,000 cells/well in a
96-well plate and allowed to attach for 20 h before drug treatment. Prior to drug exposure,
the culture medium was removed and the cells were washed once with warm phosphate-
buffered saline (PBS). Then, fresh media with drug concentrations ranging from 0 to
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100 pM (based on integrated LC-MS absorbance at 500 nm) were added to the appropriate
wells. After 10 min at 37 OC, one plate of cells was exposed to UV light (Multiple Ray Lamp
with filtered blacklight bulb, 365 nm) for 10 min while the control plate was kept in the
dark. The cells were subsequently incubated at 37 *C under a humidified atmosphere of 5%
C02 / 95% air for 24 h. The medium was removed and the cells were washed twice with
warm PBS before fresh drug-free medium was added to each well. The cells were incubated
for another 24 h before analysis by the MTT cell proliferation assay (ATCC, 30-1010K).
Cells were washed once with warm PBS and incubated with fresh medium containing MTT
reagent for 3 h at 37 'C. Detergent was added to solubilize the purple formazan crystals
formed by proliferating cells. Absorbance at 570 nm was measured on a Safire II (Tecan)
plate reader. Data were fit to a sigmoidal function to determine the half-maximum
inhibitory concentration (ICso).
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